ArticleInvestigational new drugs2020

Novel thiosemicarbazones induce high toxicity in estrogen-receptor-positive breast cancer cells (MCF7) and exacerbate cisplatin effectiveness in triple-negative breast (MDA-MB231) and lung adenocarcinoma (A549) cells.

Estefany Ingrid Medina-Reyes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.